M.A. Beckett et al. / Journal of Organometallic Chemistry 588 (1999) 107–112
111
Eqs. (1)–(4) are given below together with 1H- and
9H), 1.2 (m, 96H). 13C-NMR: l=0.0, 14.1, 17.5, 17.8,
22.7, 23.2, 29.4, 29.7, 31.9, 33.5. (nHex3SiO)3B (14):
1H-NMR: l=0.4 (t, 18H), 0.7 (t, 27H), 1.1 (m, 72H).
13C-NMR: l=14.1, 14.8, 22.7, 23.2, 31.7, 33.6.
13C-NMR data (CDCl3, RT) of compounds 10–39.
3.2. Preparation of (nBuMe2SiO)3B (10)
1
(nPr3SiO)3B3O3 (15): H-NMR: l=0.55 (m, 18H), 0.80
nBuMe2SiOH (3.73 g, 0.03 mol) was added to H3BO3
(0.58 g, 0.01 mol) in MePh (100 ml) and heated in a
Dean–Stark apparatus for 20 h until H2O (0.5 ml, 0.03
mol) had separated. The PhMe was removed from the
resulting solution by rotary evaporation leaving the
product as an analytically pure clear colourless liquid
(3.24 g, 72%) which distilled at 170°C/15 mmHg.
(t, 27H), 1.3 (m, 18H). 13C-NMR: l=16.6, 17.5, 18.3.
1
(nBu3SiO)3B3O3 (16): H-NMR: l=0.7 ( t, 27H), 0.8
(m, 18H), 1.2 (m, 36H). 13C-NMR: l=13.7, 15.4, 25.4,
26.7. (nHexyl3SiO)3B3O3 (17): 1H-NMR: l=0.7 (t,
18H), 0.9 (t, 27H), 1.3 (m, 72H). 13C-NMR: l=14.1,
1
14.5, 22.6, 22.9, 31.6, 33.2. (EtMe2SiO)3B3O3 (18): H-
NMR: l=0.2 (s, 18H), 0.65 (q, 6H), 1.0 (t, 9H).
13C-NMR: l=0.1, 6.4, 8.9. (nBuMe2SiO)3B3O3 (19):
1H-NMR: l=0.25 (s, 18H), 0.7 (t, 6H), 0.95 (t, 9H),
1.35 (q, 12H). 13C-NMR: l=0.0, 13.7, 17.1, 25.4, 26.4.
[(2-{3-cyclohexenyl}Et)Me2SiO]3B3O3 (20): 1H-NMR:
l=0.2 (s, 18H), 0.7 (m, 6H), 1.15–2.15 (m, 27H), 5.65
(q, 6H). 13C-NMR: l=0.0, 14.2, 25.3, 28.1, 29.6, 31.6,
36.3, 126.6, 126.7. [(Me2HC)(Me)2C]Me2SiO)3B3O3
3.3. Preparation of (nPr3SiO)3B3O3 (15)
nPr3SiOH (4.50 g, 0.026 mol) was added to H3BO3
(1.59 g, 0.026 mol) in MePh (100 ml) and heated in a
Dean–Stark apparatus for 20 h until H2O (0.94 ml,
0.052 mol) had separated. The PhMe was removed
from the resulting solution by rotary evaporation leav-
ing the crude product (5.04 g, 83%). The crude product
was dissolved in the minimum amount of Et2O and
filtered to removed unreacted H3BO3 (0.12 g, 0.002
mol). The Et2O was then removed under vacuum to
yield a clear colourless liquid (4.92 g, 81%) which
distilled at 260°C/1.5 mmHg.
1
(21): H-NMR: l=0.2 (s, 18H), 0.9 (s, 36H), 1.7 (sept,
3H). 13C-NMR: l=0.0, 18.5, 20.0, 24.8, 34.1.
(nOctadecylMe2SiO)3B3O3 (22): 1H-NMR: l=0.2 (s,
18H), 0.65 (q, 6H), 0.9 (t, 9H), 1.25 (m, 96H). 13C-
NMR: l=0.0, 14.1, 17.2, 17.5, 22.7, 23.0, 29.4, 29.7,
31.9, 33.4. (PhMe2SiO)3B3O3 (23): 1H-NMR: l=0.5 (s,
18H), 7.4 (d, 9H), 7.6 (m, 6H). 13C-NMR: l=0.0,
1
128.1, 130.0, 133.4, 139.0. (Ph2MeSiO)3B3O3 (24): H-
3.4. Preparation of (nPr3SiO)2BPh (26)
NMR: l=0.9 (s, 9H), 7.6 (m, 18H), 7.85 (m, 12H).
13C-NMR: l=0.0, 127.8, 128.0, 130.1, 134.2.
nPr3SiOH (3.04 g, 0.017 mol) was added to PhB(OH)2
(1.06 g, 0.00872 mol) in MePh (100 ml) and heated in a
Dean–Stark apparatus for 20 h until H2O (0.31 ml,
0.017 mol) had separated. The PhMe was removed
from the resulting solution by rotary evaporation leav-
ing the product as an analytically pure clear colourless
liquid (2.7 g, 66%).
(Ph3SiO)3B3O3 (25): H-NMR: l=7.1–7.6 (m, 45H).
1
13C-NMR: l=127.6, 129.7, 135.3. (nPr3SiO)2BPh (26):
1H-NMR: l=0.85 (m, 12H), 1.0 (t, 18H), 1.55 (m,
12H), 7.5 (d, 3H), 7.9 (t, 2H). 13C-NMR: l=16.8, 18.1,
18.3, 125.1, 127.4, 129.0, 134.9. (nBu3SiO)2BPh (27):
1H-NMR: l=0.55 (m, 12H), 0.75 (t, 18H), 1.25 (m,
24H), 7.25 (d, 3H), 7.5 (t, 2H). 13C-NMR: l=13.7,
15.0, 25.6, 26.6, 125.2, 127.2, 130.2, 134.9.
3.5. Preparation of (nBu3SnO)2BPh (35)
(Ph2MeSiO)2BPh (28): H-NMR: l=0.7 (s, 6H), 7.3–
1
7.55 (m, 20H), 7.65 (m, 5H). 13C-NMR: l=0.8, 125.3,
(nBu3Sn)2O (3.0 g, 0.0051 mol) was added to Ph-
B(OH)2 (0.63 g, 0.0051 mol) in MePh (100 ml) and
heated in a Dean–Stark apparatus for 20 h until H2O
(0.1 ml, 0.0051 mol) had separated. The PhMe was
removed from the resulting solution by rotary evapora-
tion leaving the product as an analytically pure clear
colourless liquid (2.61 g, 74%) which distilled at 250°C/
1 mmHg.
127.7, 127.9, 129.6, 130.3, 135.3, 134.2, 137.0.
(Ph3SiO)2B(C6H4Br-4) (29): H-NMR: l=7.2–7.8 (m,
1
34H). 13C-NMR: l=128.0, 128.3, 130.0, 130.2, 135.0,
135.2, 137.5. (nPr3SiO)2B(C6H4Br-4) (30): 1H-NMR:
l=0.75 (t, 12H), 1.05 (t, 18H), 1.4 (m, 12H), 7.55 (d,
2H), 7.65 (d, 2H). 13C-NMR: d=16.8, 18.0, 18.3,
125.3, 130.7, 136.5. (Ph3SiO)2B(C6H4Me-2) (31): 1H-
NMR: l=2.55 (s, 3H), 7.25 (m, 4H), 7.5 (m, 18H),
7.65 (t, 12H). 13C-NMR: l=22.5, 124.1, 127.6, 129.8,
130.1, 132.5, 135.0, 135.1, 135.3. (nPr3SiO)2B(C6H4Me-
1
(nBuMe2SiO)3B (10): H: l=0.05 (s, 18H), 0.55 (t,
6H), 0.85 (t, 9H), 1.3 (m, 12H). 13C: l=0.3, 13.7, 17.2,
1
1
24.4, 26.5. (PhMe2SiO)3B (11): H: l=0.25 (s, 18H),
2) (32): H-NMR: l=0.5 (t, 12H), 0.8 (t, 18H), 1.3 (m,
7.3 (d, 9H), 7.5 (m, 6H). 13C: l=1.3, 128.1, 129.7,
133.4, 140.1. (2-{3-cyclohexenyl}Et)Me2SiO]3B (12):
1H-NMR: l=0.0 (t, 18H), 0.6 (m, 6H), 1.0–2.0 (m,
27H), 5.5 (q, 6H). 13C-NMR: l=0.7, 15.3, 25.2, 28.6,
29.7, 31.7, 36.9, 126.7, 127.0. (nOctadecylMe2SiO)3B
12H), 2.2 (s, 3H), 6.9–7.2 (m, 4H). 13C-NMR: l=16.7,
17.8, 18.3, 28.4, 124.3, 128.5, 129.2, 132.2, 140.6.
1
(Ph3SnO)3B3O3 (33): H-NMR: l=7.2–7.45 (m, 45H).
13C-NMR:
l=128.3,
129.3,
136.2,
139.6.
(Me3SnO)3B3O3 (34): 1H-NMR: l=0.4 (27H). 13C-
1
1
(13): H-NMR: l=0.0 (s, 18H), 0.5 (t, 6H),) 0.8 (t,
NMR: l= −2.7. (nBu3SnO)2BPh (35): H-NMR: l=